Novartis buoyed by trial success in early-stage breast cancer

In a pivotal trial, Novartis' Kisqali breast cancer medication reduced the risk of recurrence in patients with early-stage disease diagnosis, boosting the company's growth prospects...

Lupin announces successful completion of Pithampur facility inspection by UK MHRA

Lupin Limited has announced the successful completion of the inspection carried out at its Pithampur facilities in India...

WHO elevates the Director-General's flagship initiative to combat tuberculosis

On the occasion of World Tuberculosis Day, the World Health Organization (WHO) announces the expansion of the WHO Director-(DG) General's Flagship Initiative on tuberculosis from 2023 to 2027 to support faster progress towards ending TB and...

Revenue of private hospitals to increase 10-11% in fiscal year 2023 and 2024; CRISIL Ratings

"Given healthy growth prospects, players rated by CRISIL Ratings have intensified bed expansion, including brownfield, since fiscal 2023," asserted Poonam Upadhyay, director of CRISIL Ratings...

Leveraging Innovation to Achieve Self-reliance in Pharmaceuticals

Indian pharmaceutical companies are planning to increase their research spending in the next five years duration. The Indian pharmaceutical market is projected to grow and reach $130 bn in the next ten years.

Sequana Medical's DSR programme receives additional patents from China & US

Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure, and cancer, has announced a significant expansion of its intellectual property portfolio for its DSR (Direct Sodium Removal) programme. A key...

US FDA approves the use of Regeneron's cholesterol drug in young children

The FDA has approved the expanded use of Regeneron Pharmaceuticals Inc's drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol levels. Evkeeza was approved in February 2021 as a supplement to other...

Orbis & PBMA's H V Desai Eye Hospital opens Green Vision Center in Satara

Orbis established the Green Vision Center (GVC) in Satara, Maharashtra, in collaboration with the PBMA's H V Desai Eye Hospital. The center's mission is to provide primary eye care and quality optical services to the communities in an...

Gennova Biopharma seeks DCGI approval for its Omicron booster

A person in the know informed sources that Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure, has filed data for its mRNA-based Omicron specific Covid-19 booster shot for approval to the drug regulator, despite an increase...

Stakeboat Capital provides Rs. 50 crore in Series-A funding to Sukino Healthcare Solutions

Sukino Healthcare Solutions, India's first comprehensive continuum of care provider for long-term healthcare management, has received a Rs. 50 crore Series-A private equity investment from Stakeboat Capital...

© 2025 India Pharma Outlook. All Rights Reserved.